Vasopressin: physiology, assessment and osmosensation

Journal of Internal Medicine

Volumn 282, Issue 4, 2017, Pages 284-297

  Bankir, L ^a,b   Bichet, D G ^c,d   Morgenthaler, N G ^e,f  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f InVivo Biotech Services GmbH   (Germany)

Author keywords

copeptin; hypothalamus; kidney; osmolality; thirst; vasopressin receptors

Indexed keywords

COPEPTIN; VANILLOID RECEPTOR 1; VASOPRESSIN; VASOPRESSIN RECEPTOR; GLYCOPEPTIDE; VASOPRESSIN DERIVATIVE;

BLOOD PRESSURE; CONFERENCE PAPER; DISEASE MARKER; DRINKING; EATING; EXERCISE; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; KIDNEY; LIVER; NONHUMAN; PANCREAS ISLET; PERCEPTION; PHYSIOLOGY; PLASMA OSMOLALITY; PRIORITY JOURNAL; SENSORY STIMULATION; SERUM OSMOLALITY; TARGET ORGAN; THIRST; VASOPRESSIN RELEASE; ANIMAL; BLOOD; OSMOREGULATION;

ANIMALS; DRINKING; EATING; GLYCOPEPTIDES; HUMANS; ISLETS OF LANGERHANS; KIDNEY; LIVER; OSMOREGULATION; RECEPTORS, VASOPRESSIN; THIRST; VASOPRESSINS;

EID: 85026318034     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12645     Document Type: Conference Paper

References (54)

1. Robertson GL. Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 2001; 30: 671–94, vii.
2. Bockenhauer D, Bichet DG. Urinary concentration: different ways to open and close the tap. Pediatr Nephrol 2014; 29: 1297–303.
3. Robertson GL. The regulation of vasopressin function in health and disease. Recent Prog Horm Res 1976; 33: 333–85.
4. Antoni FA. Vasopressin as a stress hormone. In: Fink G ed, Stress: Neuroendocrinology and Neurobiology. Academic Press, 2015; 97–108.
5. Zerbe RL, Miller JZ, Robertson GL. The reproducibility and heritability of individual differences in osmoregulatory function in normal human subjects. J Lab Clin Med 1991; 117: 51–9.
6. Thibonnier M, Coles P, Thibonnier A, Shoham M. Molecular pharmacology and modeling of vasopressin receptors. Prog Brain Res 2002; 139: 179–96.
7. Serradeil-Le Gal C, Raufaste D, Marty E, Garcia C, Maffrand JP, Le Fur G. Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059. Kidney Int 1996; 50: 499–505.
8. Perucca J, Bichet DG, Bardoux P, Bouby N, Bankir L. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists. J Am Soc Nephrol 2008; 19: 1721–31.
9. Andersen LJ, Andersen JL, Schutten HJ, Warberg J, Bie P. Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans. Am J Physiol 1990; 259: R53–60.
10. Verbalis JG. AVP receptor antagonists as aquaretics: review and assessment of clinical data. Cleve Clin J Med 2006; 73(Suppl. 3): S24–33.
11. Bankir L, Bichet DG, Bouby N. Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension? Am J Physiol Renal Physiol 2010; 299: F917–28.
12. Fenton RA. Essential role of vasopressin-regulated urea transport processes in the mammalian kidney. Pflugers Arch 2009; 458: 169–77.
13. Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 2001; 51: 372–90.
14. Bouby N, Ahloulay M, Nsegbe E, Déchaux M, Schmitt F, Bankir L. Vasopressin increases GFR in conscious rats through its antidiuretic action. J Am Soc Nephrol 1996; 7: 842–51.
15. Anastasio P, Cirillo M, Spitali L, Frangiosa A, Pollastro RM, De Santo NG. Level of hydration and renal function in healthy humans. Kidney Int 2001; 60: 748–56.
16. Bankir L, Ahloulay M, Bouby N et al. Is the process of urinary urea concentration responsible for a high glomerular filtration rate? J Am Soc Nephrol 1993; 4: 1091–103.
17. Bankir L, Bouby N, Ritz E. Vasopressin: a novel target for the prevention and retardation of kidney disease? Nat Rev Nephrol 2013; 9: 223–39.
18. Bankir L, Roussel R, Bouby N. Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea. Am J Physiol Renal Physiol 2015; 309: F2–23.
19. Clark WF, Sontrop JM, Huang SH, Moist L, Bouby N, Bankir L. Hydration and chronic kidney disease progression: a critical review of the evidence. Am J Nephrol 2016; 43: 281–92.
20. Wang CJ, Grantham JJ, Wetmore JB. The medicinal use of water in renal disease. Kidney Int 2013; 84: 45–53.
21. Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci 2008; 9: 519–31.
22. Edwards AM, Mann ME, Marfell-Jones MJ, Rankin DM, Noakes TD, Shillington DP. Influence of moderate dehydration on soccer performance: physiological responses to 45 min of outdoor match-play and the immediate subsequent performance of sport-specific and mental concentration tests. Br J Sports Med 2007; 41: 385–91.
23. Saat M, Sirisinghe RG, Singh R, Tochihara Y. Effects of short-term exercise in the heat on thermoregulation, blood parameters, sweat secretion and sweat composition of tropic-dwelling subjects. J Physiol Anthropol Appl Human Sci 2005; 24: 541–9.
24. Shirreffs SM, Merson SJ, Fraser SM, Archer DT. The effects of fluid restriction on hydration status and subjective feelings in man. Br J Nutr 2004; 91: 951–8.
25. Geelen G, Greenleaf JE, Keil LC. Drinking-induced plasma vasopressin and norepinephrine changes in dehydrated humans. J Clin Endocrinol Metab 1996; 81: 2131–5.
26. Andersen LJ, Jensen TU, Bestle MH, Bie P. Gastrointestinal osmoreceptors and renal sodium excretion in humans. Am J Physiol Regul Integr Comp Physiol 2000; 278: R287–94.
27. Prager-Khoutorsky M, Bourque CW. Mechanical basis of osmosensory transduction in magnocellular neurosecretory neurones of the rat supraoptic nucleus. J Neuroendocrinol 2015; 27: 507–15.
28. Zimmerman CA, Lin YC, Leib DE et al. Thirst neurons anticipate the homeostatic consequences of eating and drinking. Nature 2016; 537: 680–4.
29. Mandelblat-Cerf Y, Kim A, Burgess CR et al. Bidirectional anticipation of future osmotic challenges by vasopressin neurons. Neuron 2017; 93: 57–65.
30. Claybaugh JR, Sato AK, Crosswhite LK, Hassell LH. Effects of time of day, gender, and menstrual cycle phase on the human response to a water load. Am J Physiol Regul Integr Comp Physiol 2000; 279: R966–73.
31. Watts AG. Great expectations: anticipatory control of magnocellular vasopressin neurons. Neuron 2017; 93: 1–2.
32. Leib DE, Zimmerman CA, Knight ZA. Thirst. Curr Biol 2016; 26: R1260–r5.
33. Oka Y, Ye M, Zuker CS. Thirst driving and suppressing signals encoded by distinct neural populations in the brain. Nature 2015; 520: 349–52.
34. Son SJ, Filosa JA, Potapenko ES et al. Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks. Neuron 2013; 78: 1036–49.
35. Bichet DG. Vasopressin at central levels and consequences of dehydration. Ann Nutr Metab 2016; 68(Suppl. 2): 19–23.
36. Zaelzer C, Hua P, Prager-Khoutorsky M et al. DeltaN-TRPV1: a molecular co-detector of body temperature and osmotic stress. Cell Rep 2015; 13: 23–30.
37. Egan G, Silk T, Zamarripa F et al. Neural correlates of the emergence of consciousness of thirst. Proc Natl Acad Sci USA 2003; 100: 15241–6.
38. Saker P, Farrell MJ, Adib FR, Egan GF, McKinley MJ, Denton DA. Regional brain responses associated with drinking water during thirst and after its satiation. Proc Natl Acad Sci USA 2014; 111: 5379–84.
39. Kageyama K, Yamagata S, Akimoto K, Sugiyama A, Murasawa S, Suda T. Action of glucagon-like peptide 1 and glucose levels on corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells. Mol Cell Endocrinol 2012; 362: 221–6.
40. Bockenhauer D, Bichet DG. Nephrogenic diabetes insipidus. Curr Opin Pediatr 2017; 29: 199–205.
41. Lechner SG, Markworth S, Poole K et al. The molecular and cellular identity of peripheral osmoreceptors. Neuron 2011; 69: 332–44.
42. Robertson GL, Mahr EA, Athar S, Sinha T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Investig 1973; 52: 2340–52.
43. Kluge M, Riedl S, Erhart-Hofmann B, Hartmann J, Waldhauser F. Improved extraction procedure and RIA for determination of arginine 8-vasopressin in plasma: role of premeasurement sample treatment and reference values in children. Clin Chem 1999; 45: 98–103.
44. Steiner DF. On the discovery of precursor processing. Methods Mol Biol 2011; 768: 3–11.
45. Levy B, Chauvet MT, Chauvet J, Acher R. Ontogeny of bovine neurohypophysial hormone precursors. II. Foetal copeptin, the third domain of the vasopressin precursor. Int J Pept Protein Res 1986; 27: 320–4.
46. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006; 52: 112–9.
47. Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL. Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci (Lond) 2009; 116: 257–63.
48. Keller T, Tzikas S, Zeller T et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010; 55: 2096–106.
49. Perucca J, Bouby N, Valeix P, Bankir L. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol 2007; 292: R700–5.
50. Roussel R, Fezeu L, Marre M et al. Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J Clin Endocrinol Metab 2014; 99: 4656–63.
51. Szinnai G, Morgenthaler NG, Berneis K et al. Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab 2007; 92: 3973–8.
52. Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Rutishauser J. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. J Clin Endocrinol Metab 2011; 96: 1046–52.
53. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007; 28: 219–26.
54. Staub D, Morgenthaler NG, Buser C et al. Use of copeptin in the detection of myocardial ischemia. Clin Chim Acta 2009; 399: 69–73.